| Literature DB >> 29935688 |
Claire Yue Li1, H Richard Alexander2.
Abstract
Diffuse malignant peritoneal mesothelioma (MPM) is a rare cancer that is ultimately fatal in almost all afflicted individuals. Morbidity and mortality from MPM is due to its propensity to progress locoregionally within the abdominal cavity. Patients with MPM most commonly present with nonspecific abdominal symptoms that usually lead to diagnosis when the condition is relatively advanced. MPM is considered a chemotherapy-resistant malignancy.Entities:
Keywords: Diffuse malignant peritoneal mesothelioma; Early postoperative intraperitoneal chemotherapy; Hyperthermic intraoperative peritoneal chemotherapy; Operative cytoreduction; Peritoneal metastases
Mesh：
Year: 2018 PMID： 29935688 DOI： 10.1016/j.soc.2018.02.010
Source DB: PubMed Journal: Surg Oncol Clin N Am ISSN： 1055-3207 Impact factor: 3.495